Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili, Zurab; Nguyen, Ngon T; Gorell, Emily S; Loutit, Kylie; Khuu, Phuong; Furukawa, Louise K; Lorenz, H Peter; Leung, Thomas H; Keene, Douglas R; Rieger, Kerri E; Khavari, Paul; Lane, Alfred T; Tang, Jean Y; Marinkovich, M Peter.
; 316(17): 1808-1817, 2016 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-27802546
Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico.
Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn.
An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred.
Compound Heterozygosity of Dominant and Recessive COL7A Alleles in a Severely Affected Patient with a Family History of Dystrophic Epidermolysis Bullosa: Clinical Findings, Genetic Testing, and Treatment Implications.
Épidermolyse bulleuse héréditaire dystrophique par hétérozygotie composite COL7A1.
Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations.
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.